Assidicky, Ridho
Tokat, Unal Metin
Tarman, Ibrahim Oguzhan
Saatci, Ozge
Ersan, Pelin Gulizar
Raza, Umar
Ogul, Hasan
Riazalhosseini, Yasser
Can, Tolga
Sahin, Ozgur http://orcid.org/0000-0002-8033-7089
Funding for this research was provided by:
Marie Curie (PCIG14-GA-2013-631149)
American Cancer Society (IRG-17-179-04)
Higher Education Commision, Pakistan
Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Susan G. Komen (GTDR17500160)
Fonds de Recherche du Québec - Santé
National Cancer Institute (R01-CA267101)
National Institute of General Medical Sciences (2P20GM109091-06)
Article History
Received: 6 December 2021
Accepted: 13 March 2022
First Online: 25 March 2022
Declarations
:
: O.S. is the co-founder and manager of OncoCube Therapeutics LLC and founder and president of LoxiGen, Inc. The other authors declare no potential conflict of interest.